SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017442
Filing Date
2022-11-10
Accepted
2022-11-10 16:30:59
Documents
82
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eqrx-20220930x10q.htm   iXBRL 10-Q 1997608
2 EX-10.1 eqrx-20220930xex10d1.htm EX-10.1 19843
3 EX-10.2 eqrx-20220930xex10d2.htm EX-10.2 26785
4 EX-31.1 eqrx-20220930xex31d1.htm EX-31.1 18753
5 EX-31.2 eqrx-20220930xex31d2.htm EX-31.2 18087
6 EX-32.1 eqrx-20220930xex32d1.htm EX-32.1 13741
7 GRAPHIC eqrx-20220930x10q002.jpg GRAPHIC 115384
  Complete submission text file 0001558370-22-017442.txt   8518651

Data Files

Seq Description Document Type Size
8 EX-101.SCH eqrx-20220930.xsd EX-101.SCH 54590
9 EX-101.CAL eqrx-20220930_cal.xml EX-101.CAL 42914
10 EX-101.DEF eqrx-20220930_def.xml EX-101.DEF 246718
11 EX-101.LAB eqrx-20220930_lab.xml EX-101.LAB 483137
12 EX-101.PRE eqrx-20220930_pre.xml EX-101.PRE 407695
76 EXTRACTED XBRL INSTANCE DOCUMENT eqrx-20220930x10q_htm.xml XML 1491927
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40312 | Film No.: 221377800
SIC: 2834 Pharmaceutical Preparations